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Letters to the Editorfollow surgical oncologic principles
and should be regarded as a bailout
procedure and used judiciously.
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HETEROGRAFT VALVE
CALCIFICATION PLEASE
STAND UP?
To the Editor:
Sinha and colleagues1 are not the
first to implicate glutaraldehyde as
a culprit for tissue valve calcification.
Although they are to be commended
for their careful methods and the sug-
gestion that glutaraldehyde concentra-
tion and exposure times appear to
correlate with the degree of calcifica-
tion, they unfortunately failed to reach
far enough back into the literature to
recognize that most of their questions
had already been answered by others.2
A closer look at the literature might
also have led these researchers to ar-
rive at a different conclusion; that is,
calcific degeneration of heterograft
tissues is primarily an immunologic
phenomenon.
Alain Carpentier and his wife So-
phie, a biochemist, are given credit
for the introduction of aldehyde chem-
istry to themodernmanufacture of het-
erograft tissue valves.3 At the time,
they did not advance an argument
that aldehyde preservation rendered
heterograft tissues nonimmunogenic.
That perception belongs to perspica-
cious marketing departments within
the tissue valve industry. The observa-
tion that calcific degeneration of het-
erograft valves is an age-relatedThe Journalphenomenon was an early and impor-
tant clue to the problem of tissue valve
durability.4 These issues notwithstand-
ing, the Carpentiers’ discovery had al-
ready spawned the multibillion dollar
industry of heterograft tissue heart
valves.
More than30years ago, Salgaller and
Bajpai5 detected both cellular and
humoral immune responses to
glutaraldehyde-treated and untreated
bovine pericardium. Their data pro-
vided the first real proof that
glutaraldehyde-preserved heterograft
tissues are not biologically inert and re-
main antigenic. The association be-
tween a smoldering immune response
and tissue valve durability was never
widely recognized,however, andglutar-
aldehyde continued to be the presumed
cause of heterograft calcification, lead-
ing researchers and companies to search
for new tissue treatments designed to re-
tard calcification.
Love and associates6 first described
the successful use of autologous peri-
cardium briefly treated in 0.6%
glutaraldehyde for use as a stent-
mounted valve replacement. Since
this introduction, multiple investiga-
tors have reported wide success with
the use of autologous pericardium
briefly treated in 0.6% glutaraldehyde
for the replacement of semilunar heart
valves7 and the repair of damaged and
shortened mitral valve leaflets.8 All
these techniques have proved durable,
and in none of the published experi-
ences, including those with pediatric
or very young patients, has calcific
degeneration been considered
a limitation.
The more than 20-year clinical ex-
perience with autologous pericardium
briefly immersed in glutaraldehyde
and used for valve reconstruction
should finally dispel any perception
that aldehydes are directly responsible
for calcific degeneration of tissue
valves.
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We thank Mr Love for responding
to our article1 and for emphasizing
the importance of immune mecha-
nisms in heterograft calcification. We
are in agreement that aldehyde treat-
ment is just one of several factors
that can exacerbate calcification of
implanted tissues. In the clinical set-
ting of pediatric cardiac surgery,
where autologous pericardium is often
used and immune mechanisms are
presumably not so important, how-
ever, it is the factor that can be most
readily modified. Unfortunately, our
animal model was not suited to autol-
ogous pericardium implantation.
We strongly disagree with Mr
Love’s assertion that calcific degener-
ation never occurs in the pediatric
setting when glutaraldehyde-treated
autologous pericardium is used forry c Volume 144, Number 1 285
Letters to the Editorvalve reconstruction. For example,
Bacha and colleagues2 described an
important incidence of late failure
because of calcification in an
aortic valve repair with autologous
pericardium.
We were surprised by the finding of
our study that shorter pretreatment
duration was associated with greater
calcification, suggesting that longer
but nevertheless clinically feasible
pretreatment times should be used.
In the future, we are interested in ex-
ploring the efficacy of the many anti-
calcification treatments that have
been applied to xenograft valves in
the hope that they might be effective
in reducing the degree of calcification
of autologous pericardium in the pedi-
atric setting.
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BYPASS MODEL IN RATS
To the Editor:
We readwith great interest the study
for theestablishmentof acardiopulmo-
nary bypass (CPB) model in rats titled
‘‘Rat model of cardiopulmonary by-
pass for deep hypothermic circulatory
arrest’’ by Waterbury and colleagues,1
showing that they had successfully de-
veloped a rat CPBmodelwith deep hy-
pothermia circulatory arrest for the
research of postoperative neurocogni-
tive function. The authors mentioned286 The Journal of Thoracic and Cthat their model had several innovative
elements, including peripheral cannu-
lation, instead of thoracotomy or ster-
notomy, the lack of a need for
tracheal intubation with mechanical
ventilation, and so on.
However, some confusion was
aroused by these innovations. First,
we wonder whether peripheral cannu-
lation, instead of thoracotomy or
sternotomy, should be truly called inno-
vative. Logically, to investigate postop-
erative cognitive function in rats
undergoing cardiac surgery or CPB,
the experimental ratsmust be alive after
the induced surgical trauma for the sub-
sequent cognitive assessment. There-
fore, to date, for all those CPB models
in rats that need to survive, thoracot-
omy or sternotomy is avoided. How-
ever, there is an exception. In the
research of perioperative myocardium
injury in rats using the CPB model
fromG€unzinger and colleauges,2 cardi-
oplegic arrest was achieved through
cardioplegia injection by direct aortic
clamping. To achieve access to the as-
cending aortic artery for cardioplegia
injection, sternotomy was performed,
and cannulation and ligation of the
bilateral carotid arteries were also per-
formed; thus, theoretically, the survival
of the experimental rats was close to
impossible.
Second, the authors stressed that
the rats undergoing CPB were not in-
tubated and not ventilated, which is
fully beyond our knowledge. Without
tracheal intubation and mechanical
ventilation, how would it be possible
to maintain proper anesthesia, be-
cause we also know that too deep an
anesthesia will compromise the respi-
ration and hemodynamics. However,
the rats might move under a light an-
esthesia. In addition, without support-
ive ventilation, coming off CPB will
undoubtedly be very challenging for
the rats buffeted by the sluggish circu-
lation during the rewarming period.
More importantly for the CPB model
in the research by Waterbury and col-
leagues,1 the CPB flow was incom-
plete, which was about 70% ofardiovascular Surgery c July 2012normal cardiac output, according to
their report. Thus, how to oxygenate
the other 30% of the blood? Under
such circumstances, desaturation
would gradually occur, which was evi-
denced by the severely reduced pH and
base excess in their Table 1 for the
physiologically relevant parameters
of rats undergoing CPB with deep
hypothermia circulatory arrest.
Third, we noted that no vein chan-
nel was established for medicine ad-
ministration. When coming off CPB,
the rats might need some inotropes;
however, at that time, all the cannulas
used for CPB have been extracted and
the corresponding vessels ligated.
Finally, bilaterally, the femoral ar-
teries were cannulated and also would
have been ligated after surgery, which
would produce some difficulties
for the motor function of those
experimental animals, although the
experiment was performed for neuro-
logic evaluation after surgery.
In the Duke Anesthesiology CPB
laboratory, the CPB model in rats
was instituted at a flow rate of 160 to
180 mL/kg/min, the normal cardiac
output of rats. All the experimental
rats were also intubated and ventilated
for the purposes of both anesthesia
and oxygenation. Additionally, thora-
cotomy or sternotomy was avoided
to ensure the survival of the rats.
Also, the superficial caudal epigastric
artery and vein, instead of the femoral
artery and vein, were cannulated for
continuous measurement of the mean
arterial pressure and for intravenous
drug administration to ensure better
survival.3,4
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